معرفی
Professor Rongjun Chen is a Professor of Biomaterials Engineering at the Department of Chemical Engineering, Imperial College London. He holds affiliations with multiple research centers, including the CDT in Chemical Biology, Cancer Technology Network, and the Vaccine Research Network. His research focuses on biomaterials, nanomedicine, and biomedical engineering, with notable contributions to drug delivery systems, RNA vaccine formulation, and targeted therapies for cancer and thrombosis. He has pioneered technologies like thermally robust lipid nanoparticles for vaccine stabilization and fibrinogen-mimicking nanoparticles for thrombus targeting.
Prof. Chen earned his PhD in Chemical Engineering from the University of Cambridge (2007) and held postdoctoral roles at Cambridge and Leeds before joining Imperial in 2013. He leads projects such as the GSK partnership to eliminate cold-chain storage for RNA vaccines and has developed DMSO-free cryopreservation methods for cell therapies. His work bridges chemical engineering principles with biomedical applications, emphasizing translational research.
Key research areas include: 1) Smart drug delivery systems for enhanced tumor penetration and immune activation; 2) Biocompatible materials for nucleic acid and cell preservation; 3) Targeted nanomedicines for cardiovascular diseases and cancer. Recent articles highlight advancements in enzyme-responsive polymers, mitochondrial targeting therapies, and coacervate-based drug formulations.
His grants and partnerships focus on scaling up nanotechnology for clinical use. Labs/teams include the Imperial College Centre for Advanced Therapeutics and the Institute of Chemical Biology. No scientific awards are explicitly listed in the provided text.
